Zelira Therapeutics Ltd ZLD
Trading Information
- Previous Close Price
- A$0.50
- Day Range
- A$0.49–0.50
- 52-Week Range
- A$0.31–1.15
- Bid/Ask
- A$0.00 / A$0.00
- Shares Outstanding
- 13.15M
- Market Cap
- A$5.95M
- Volume/Avg
- 19,140 / 46,658
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 8,771.93
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Zelira Therapeutics Ltd is a biotechnology company focused on developing a range of cannabinoid-based formulations for the treatment of various medical conditions in Australia. The company is involved in a human clinical trial program focused on insomnia, autism, and eczema, and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer. The company is organised into two operating segments based on geographic location of operations: Australia and United States of America.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 8
- Website
- https://www.zeliratx.com
Valuation
|
Metric
|
ZLD
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 8,771.93 |
Price/Cash Flow | — |
Price/Earnings
ZLD
Financial Strength
|
Metric
|
ZLD
|
|---|---|
Quick Ratio | 0.01 |
Current Ratio | 0.11 |
Interest Coverage | — |
Quick Ratio
ZLD
Profitability
|
Metric
|
ZLD
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
ZLD
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|!L?&FF! | LOCK|@hS% | $129B | |||
| Moderna Inc
MRNA
| LOCK|T$QW^T | LOCK|nhR | $85B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|yQ%Cj$ | LOCK|%r<V | $79B | |||
| argenx SE ADR
ARGX
| LOCK|Gmb@Z> | LOCK|c#@ | $52B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|t$d%Zn | LOCK|pV | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|Ygj<Nh# | LOCK|F!J@R | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|LGs^#m& | LOCK|KX^M | $26B | |||
| BioNTech SE ADR
BNTX
| LOCK|kxB@?% | LOCK|LGz | $24B | |||
| Incyte Corp
INCY
| LOCK|XPSC#> | LOCK|<ZM | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|%y#MB$H | LOCK|Z% | $14B |
United States